This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier.
This means that if you invested $100 now, your current investment may be worth 471.836$ on 2023 January 19, Thursday.
CBD of Denver stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.
As of 2022 January 19, Wednesday current price of CBDD stock is 0.004$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
1 year CBD of Denver price prediction
Future price of the stock is predicted at 0.018873449472437$ (371.836% ) after a year according to our prediction system.
Our site uses a custom algorithm based on Deep Learning that helps our users to decide if CBDD could be a good portfolio addition. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks.
!! *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn’t been used for investment decision. Past success does not guarantee future profit !!
14 days CBD of Denver price prediction
Return vs Industry : CBD underperformed the NZ Pharmaceuticals industry which returned -12.4% over the past year.
Cannasouth Limited (NZSE:CBD) signed an agreement to acquire remaining 50% stake in Cannasouth Cultivation Limited from Aaron Craig on July 4, 2021. Under the terms of the consideration, Cannasouth will acquire the remaining 50% of the shares on issue in Cannasouth Cultivation which it does not already own, together with all of the shareholder loans made to Cannasouth Cultivation by the Craig Family interests. The transaction will be settled as follows: an upfront payment of NZD 2 million at closing, NZD 0.5 million payment each after 12 and 18 months of closing of transaction and issuance of new stock amounting to NZD 0.54 million. In a separate transaction, Cannasouth agreed to acquire remaining 40% of stake in Midwest Pharmaceutics NZ Limited from Greenmeadows Health Limited and Mark Balchin for NZD 1 million. The transaction is subject to capital raising of NZD 6 million by September 30, 2021. Cannasouth Limited (NZSE:CBD) completed the acquisition of remaining 50% stake in Cannasouth Cultivation Limited from Aaron Craig on November 30, 2021.
Stable Share Price : CBD is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 4% a week.
Insider recently sold NZ$607k worth of stock
The company is down 20% from its price of NZOn the 20th of November, Nicholas Foreman sold around 351k shares on-market at roughly NZCannasouth Limited, a biopharmaceutical company, engages in the research, development, production, and supply of cannabis biomass and cannabinoid medicines in New Zealand..56 per share. In the last 3 months, they made an even bigger sale worth NZ$445k. Insiders have been net sellers, collectively disposing of NZ$2.9m more than they bought in the last 12 months..66 on 27 November 2020. The New Zealander market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 13% over the same period.
Volatility Over Time : CBD's weekly volatility (4%) has been stable over the past year.
On the 27th of November, Nicholas Foreman sold around 994k shares on-market at roughly NZIt is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also..61 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of NZ$3.5m more than they bought in the last 12 months.
Price History & Performance
Full year 2020 results: Net loss: NZ$3.55m (loss widened 63% from FY 2019).
Return vs Market : CBD underperformed the NZ Market which returned -6.2% over the past year.